Applied DNA Sciences, Inc.
APDN
$3.03
-$0.23-7.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.94M | -5.94M | -10.41M | -8.87M | -9.17M |
| Total Depreciation and Amortization | 135.60K | 135.60K | 321.90K | 562.30K | 815.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.90K | -66.90K | 976.80K | -1.12M | -1.46M |
| Change in Net Operating Assets | -707.60K | -707.60K | -677.10K | -791.30K | 170.00K |
| Cash from Operations | -9.76M | -13.25M | -13.28M | -13.71M | -13.14M |
| Capital Expenditure | -488.20K | -488.20K | -503.00K | -386.10K | -939.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -673.50K | -695.30K | -524.80K | -407.90K | -961.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.31M | 6.31M | 9.24M | 2.98M | 2.98M |
| Repurchase of Common Stock | -390.70K | -390.70K | -390.70K | -390.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 80.60K | 0.00 | 0.00 |
| Cash from Financing | 6.81M | 17.62M | 19.74M | 13.40M | 13.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.62M | 3.67M | 5.94M | -720.70K | -314.10K |